Diana Mandelker
Affiliations: | 2010 | Johns Hopkins University School of Medicine, Baltimore, MD, United States |
Google:
"Diana Mandelker"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Varghese AM, Perry MA, Chou JF, et al. (2025) Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival. Nature Medicine |
| Franch-Expósito S, Mehine M, Ptashkin RN, et al. (2023) Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors. Jco Precision Oncology. 7: e2300070 |
| Murciano-Goroff YR, Schram AM, Rosen EY, et al. (2022) Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies. Nature Communications. 13: 7182 |
| Ozer M, Ranganathan M, Lecomte N, et al. (2022) Concurrent Germline / and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options. Jco Precision Oncology. 6: e2100560 |
| Manning-Geist B, Gordhandas S, Liu YL, et al. (2022) MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| El Jabbour T, Misyura M, Cowzer D, et al. (2022) ATM Germline Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics and Potential Therapeutic Implications. Journal of the National Cancer Institute |
| Pareja F, Ptashkin RN, Brown DN, et al. (2021) Cancer Causative Mutations Occurring in Early Embryogenesis. Cancer Discovery |
| Chui MH, Yang C, Mehta N, et al. (2021) Somatic intronic TP53 c.375+5G mutations are a recurrent but under-recognized mode of TP53 inactivation. The Journal of Pathology. Clinical Research |
| Stadler ZK, Maio A, Chakravarty D, et al. (2021) Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003661 |
| Samstein RM, Krishna C, Ma X, et al. (2021) Mutations in and differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. Nature Cancer. 1: 1188-1203 |